November 29, 2024
Bulletin interne de l'Institut Pasteur
The neuromuscular blockade reversal agents, capable of reversing the effect of neuromuscular blocking agents (NMBAs) at the end of anesthesia and therefore restoring muscle function upon resuscitation, represent a medical and economic breakthrough. A team led by Institut Pasteur scientist Pierre Bruhns has worked on the development a new generation of neuromuscular blockade reversal agents.